AlphaMark Advisors’s Quest Diagnostics DGX Stock Holding History

AlphaMark Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-18	Closed	-$2K	–	489
2019 Q3	$2K	Buy	+18	New	+$1.85K	﹤0.01%	450

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaMark Advisors's DGX Position: Q4 2019 in Review

AlphaMark Advisors sold out of Quest Diagnostics (DGX) in Q4 2019, closing a stake of 18 shares — an estimated $2K sold.

AlphaMark Advisors first reported a position in DGX in Q3 2019 and held it in 1 quarter. The position peaked at $2K in Q3 2019. 711 funds tracked by Wall St. Rank hold DGX as of Q4 2019.

AlphaMark Advisors reported no remaining Quest Diagnostics position as of Q4 2019 after selling out during the quarter.
AlphaMark Advisors sold 18 Quest Diagnostics shares in Q4 2019, an estimated $2K.
AlphaMark Advisors first reported a position in Quest Diagnostics in Q3 2019 and held it in 1 quarter.
AlphaMark Advisors's Quest Diagnostics position peaked at $2K in Q3 2019.
711 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.